GxP , and 21 CFR Part 11 Compliance in Mexico: What It Requires of Your IT Infrastructure

Why are GxP , and 21 CFR Part 11 important to a subsidiary in Mexico?

If your company is part of a pharmaceutical company, a medical device manufacturer, or a CRO/CMO that reports to a parent company regulated by the U.S. Food and Drug Administration ( FDA ) (or by European equivalents such as EMA/Annex 11), compliance with GxP is neither optional nor limited to plants or laboratories. It extends to any IT system that generates, modifies, or maintains records used for regulatory decisions: quality ERP , document management systems, manufacturing platforms, and even email and repositories where evidence for a batch or a clinical study is stored.

GxP It is the umbrella term that encompasses Good Manufacturing Practices (GMP), Good Laboratory Practices (GLP), and Good Clinical Practices (GCP). The regulation that places the greatest responsibility on the IT department is 21 CFR Part 11, the U.S. Food and Drug Administration’s ( FDA ) regulation on electronic records and signatures.

What 21 CFR Part 11 Requires of Your IT Infrastructure

• Audit trails generated by the system itself, including the exact date and time of each action, the user's unique identifier, and the reason for the change when a regulated record is modified.
• Immutability: Audit trails must be permanent, unalterable, and protected against deletion, even by system administrators.
• Retention: Audit documentation must be retained for at least as long as the electronic record to which it pertains—there is no general time frame; it depends on the type of record.
• Role-based access control, with unique credentials for each user (no shared operator or IT accounts).
• An electronic signature linked to the registry—not just a checkbox—must be permanently associated with the data it certifies.
• Documented system validation: evidence that the platform does what it claims to do, before it goes into production.
• Secure timestamps, using a validated and synchronized time source.

A Practical IT Checklist for a Subsidiary

• Do your critical systems generate an automatic audit trail, or does it depend on someone manually activating or reviewing it?
• Is there a log retention policy that aligns with the document retention requirements set by your parent company, or do the logs roll over every 30–90 days by default?
• Is there an up-to-date access control matrix that documents user additions and removals when someone changes roles or leaves the company?
• Is the change process (patches, updates, new integrations) documented using change control, or is it implemented "on the fly" without being logged?
• Are the backups and service continuity measures designed to ensure that no regulatory evidence is lost if a server fails?

What happens if the terms aren't met?

For a FDA-regulated operation, an incomplete or tamperable audit trail is not just an internal audit finding: it is grounds for a 483 observation or, in serious cases, a warning letter that can halt shipments or approvals. For the Mexican subsidiary, the reputational cost vis-à-vis the parent company often carries as much weight as the regulatory cost—it is evidence that the local operation does not measure up to the rest of the network.

How a Well-Designed IT Management System Solves This

Most of these requirements do not call for exotic technology: they require sustained operational discipline —properly configured and monitored logging, up-to-date access controls, documented change control, and tested backups, not just scheduled ones. This is precisely the realm of a periodic IT audit and cybersecurity management with formal processes, rather than purchasing a new tool.

If your subsidiary reports to a parent company regulated by FDA or EMA, it’s worth going through this process before an external auditor does.